Pharmaceutical composition for treating diabetic nephropathy

Abstract

The invention relates to a pharmaceutical composition for treating diabetic nephropathy. Based on traditional Chinese medicine theories, the pharmaceutical composition comprises traditional Chinese medicine raw material medicines such as cooked rehmannia root, astragalus root, polygonati, salvia root, Chinese yam, white atratylodes rhizome, atractylodes rhizome, notoginseng root, alisma rhizome, and poria, has the effects of tonifying qi and yin, and clearing dampness and dredging collaterals; and is used for treating the diabetic nephropathy.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a pharmaceutical composition for treating diabetic nephropathy; it belongs to the technical field of medicine. Background technique [0002] Diabetic nephropathy (DN) is one of the common microvascular complications of diabetes and one of the main causes of death in diabetic patients. Data show that DN is about 36.39% in end-stage renal failure (ESRF) patients in the United States, 7.9% in Europe, 16% in Japan, and about 5% in my country. Although the current incidence rate in my country is lower than that in western countries, with the rapid improvement of people's living standards, the extension of life expectancy and the change of diet structure, the incidence and prevalence of diabetes are increasing year by year. The number of patients is much higher than that in western countries, and DN will definitely become one of the main causes of end-stage renal disease. ...

AI Technical Summary

Problems solved by technology

However, the side effects of chemical medicines increase, and long-term use will enhance human tolerance and greater dependence, so it is necessary to develop traditional Chinese medicine preparations with less toxic and side effects